...
首页> 外文期刊>Journal of Oral and Maxillofacial Surgery >Propofol Versus Remifentanil: Which One Is More Effective in Reducing Blood Loss During Orthognathic Surgery? A Randomized Clinical Trial
【24h】

Propofol Versus Remifentanil: Which One Is More Effective in Reducing Blood Loss During Orthognathic Surgery? A Randomized Clinical Trial

机译:异丙酚与雷芬丹尼尔:哪一个更有效地降低正畸手术期间的血液损失? 随机临床试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PurposePropofol and remifentanil are 2 useful drugs used in induced hypotensive anesthesia. The purpose of this study was to compare the effects of these drugs on intraoperative blood loss, transfusion requirements, and hemodynamic status during standardized orthognathic surgical procedures. Materials and MethodsIn this double-blind randomized clinical trial, 50 consecutive healthy patients with Class III skeletal deformity were candidates for bimaxillary orthognathic surgery at Qaem Hospital, Mashhad University of Medical Sciences (Mashhad, Iran), from November 2016 until December 2017. These patients were randomly assigned to 2 equal-number groups to receive hypotensive anesthesia with propofol or remifentanil. Neither the surgeon nor the patients were aware of the study groups, whereas both the student and anesthesiologist were not blinded. Age and gender were recorded, and mean blood loss, mean arterial pressure, and mean heart rate, as well as duration of surgery and duration of general anesthesia, were monitored intraoperatively.?The hypotensive anesthetic drugs were the primary predictor variables and the mean blood loss volume was the main outcome in this research. The independentttest and χ2test were performed for data analysis using SPSS software (version 16; SPSS, Chicago, IL). ResultsIn this study, 25 patients with a mean age of 22.25?±?3.31?years were investigated in each group. The mean blood loss volume was 578.26?±?95.14?mL and 366.67?±?64.92?mL in the propofol and remifentanil groups, respectively. The independent-samplesttest showed that mean blood loss was significantly lower in the remifentanil group than in the propofol group (P?=?.001). Furthermore, the mean arterial blood pressure was significantly lower in the remifentanil group than in the propofol group (85?±?20?mm Hg vs 95?±?15?mm Hg,P?
机译:目的脯醇和雷芬丹尼尔是2种有用的药物用于诱导的低血压麻醉。本研究的目的是比较这些药物对标准正畸外科手术过程中的术中失血,输血要求和血流动力学状态的影响。材料和方法在这种双盲随机临床试验中,连续50名患有III级骨骼畸形的患者,是2016年11月至2017年12月至2017年12月的QAEM医院(MASHHAD)伊朗医院骨髓畸形患者的候选人随机分配给2个等分数组,以接受与异丙酚或雷芬丹尼尔的低血压麻醉。外科医生和患者都不了解研究组,而学生和麻醉师都没有蒙蔽。记录年龄和性别,并且平均失血,平均动脉压和平均心率,以及手术持续时间和全身麻醉的持续时间被术上监测。过度麻醉药物是主要预测因子变量和平均血液损失量是本研究的主要结果。使用SPSS软件(版本16; SPSS,Chicago,IL)执行独立的TTEST和χ2Test进行数据分析。结果本研究,25例平均年龄为22.25岁?±3.31?每组调查。平均血液损失体积分别为578.26〜±95.14×ml和366.67×±64.92×64.92毫升,分别在丙莫啉和雷芬丹内尼基团中。独立的Samplesttest表明,雷芬内尼尼群中的平均血液损失显着低于丙糊组基团(P?= 001)。此外,雷芬内尼尼群中的平均动脉血压显着低于双丙烯酚基团(85〜±20×20?mm Hg vs 95?±15?mm hg,p?<001)。结论与雷芬丁内尼亚尔的血清型麻醉,与异丙酚相比,在正畸手术期间显着降低了平均失血,这降低了输血和输血和失血的缺点。

著录项

  • 来源
  • 作者单位

    Oral and Maxillofacial Diseases Research Center Mashhad University of Medical Sciences;

    Oral and Maxillofacial Diseases Research Center Mashhad University of Medical Sciences;

    Endoscopic &

    Minimally Invasive Surgery Research Center Department of Anesthesiology Qaem;

    Oral and Maxillofacial Diseases Research Center Mashhad University of Medical Sciences;

    Student Research Committee Dentistry Faculty Mashhad University of Medical Sciences;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 口腔科学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号